Intake of different eicosapentaenoic acid‐containing lipids and fatty acid pattern of plasma lipids in the rats
- 1 December 1987
- Vol. 22 (12) , 994-998
- https://doi.org/10.1007/bf02536438
Abstract
The ethyl ester of eicosapentaenoic acid (EPA) is the only pure EPA-containing lipid available in bulk for oral administration. However, there is doubt as to whether EPA ethyl ester can efficiently increase the plasma levels of EPA in comparison with the ability of other kinds of EPA-containing lipids to do so. Therefore, two other kinds of EPA-containing lipids were prepared to study the efficiency of oral administration of those lipids for increasing the EPA content in plasma phospholipids and cholesteryl esters. EPA-containing lipids which were investigated were [A], 1,2,3-trieicosapentaenoyl-glycerol, [B] 2-eicosapentaenoyl-phosphatidylcholine and [C] ethyl ester of EPA. An adjusted amount of lipids [A], [B] and [C] was administered to rats through a gastric tube for 4 days (the first experiment) or for 10 days (the second experiment), and the fatty acid composition of plasma phospholipids and cholesteryl esters was determined. In the first experiment, there were no significant differences in the efficiency for increasing EPA levels in either phospholipids or cholesteryl esters among the lipids. In the second experiment, the EPA levels of both plasma phospholipids and cholesteryl esters of rats administered ethyl ester of EPA were significantly higher than those of rats administered 2-eicosapentaenoyl-phosphatidylcholine. The EPA levels of the rats administered 1,2,3-trieicosapentaenoylglycerol were between the levels of the two groups mentioned above, but the differences in the EPA levels were not significant. Although an ethyl ester-type molecule is not a naturally occurring lipid, ethyl ester of EPA is equal to 1,2,3-trieicosapentaenoyl-glycerol and appears to be superior to 2-eicosapentaenoyl-phosphatidylcholine as to the efficiency for increasing EPA levels in total plasma phospholipids and plasma cholesteryl esters.This publication has 24 references indexed in Scilit:
- Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.Journal of Clinical Investigation, 1985
- Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patientsKidney International, 1984
- Effect of dietary cod-liver oil on the lipid composition of human erythrocyte membranesScandinavian Journal of Clinical and Laboratory Investigation, 1984
- Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acidNature, 1984
- Lipid and blood pressure-lowering effect of mackerel diet in manAtherosclerosis, 1983
- Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjectsAtherosclerosis, 1983
- EFFECT OF FISH OIL ON PLATELET KINETICS IN PATIENTS WITH ISCHAEMIC HEART DISEASEThe Lancet, 1982
- The effect of dietary supplements of ω3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglyceridesBritish Journal of Nutrition, 1981
- PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIETThe Lancet, 1980
- The Composition of Food Consumed by Greenland EskimosActa Medica Scandinavica, 1976